Waleed Arafat, President of ISCO and Professor of Clinical Oncology at University of Alexandria, shared a post on LinkedIn:
“Interested data, genomic based therapy improve OS, but only when supported by prospective clinical trial evidence.”
Title: Genomic Therapy Matching in Rare and Refractory Cancers
Authors: Frank P. Lin, Subotheni Thavaneswaran, John P. Grady, Christine E. Napier, Maya Kansara, Lucille Sebastian, Damien Kee, Jayesh Desai, Milita Zaheed, Sarah Chinchen, Samantha R. Oakes, James Blackburn, Hamish S. Scott, Anthony Glover, Stephen B. Fox, David Goldstein, Paul Leo, Benhur Amanuel, Antony Mersiades, Michael Millward, Michael P. Brown, Michail Charakidis, Adrian M. J. Pokorny, Paul Craft, David Espinoza, Peter Grimison, Rosemary Harrup, Anthony M. Joshua, Ken O’Byrne, Chee Khoon Lee, Mark J. Cowley, Mandy L. Ballinger, John Simes, David M. Thomas the Australian Molecular Screening and Therapeutic program investigators and contributors
Other articles featuring Waleed Arafat on OncoDaily.